CURRENT
ISSUE
1547

The FDA has approved a lower-dose epinephrine auto-injector (Auvi-Q 0.1 mg – Kaléo) for emergency treatment of anaphylaxis in children weighing 7.5-15 kg (16.5-33 lbs). It is the first epinephrine auto-injector to be approved for use in infants and toddlers weighing less than 15 kg. Previously, Auvi-Q and other epinephrine auto-injectors were only available in 0.15- and 0.3-mg strengths for patients weighing 15-30 kg or ≥30 kg, respectively.1

The recommended dose of epinephrine for intramuscular (IM) or subcutaneous (SC) administration is 0.01 mg/kg. None of the previously available epinephrine auto-injectors provided a weight-appropriate dose for infants, so many physicians prescribed a 0.15-mg auto-injector off-label for this age group.2

The Auvi-Q device is about the length and width of a credit card and as thick as a cell phone. It has an automatic needle retraction system...  Continue reading

More from Issue 1547
Previous Issue: 1546      May 7, 2018
Coming Soon
Meropenem/Vaborbactam (Vabomere) for Urinary Tract Infections
Pitavastatin Magnesium (Zypitamag) for Hyperlipidemia
Angiotensin II (Giapreza) for Septic Shock
Hemophagocytic Leukohistiocytosis with Lamotrigine
Diet, Drugs, Devices, and Surgery for Weight Management
Search
Subscribe
Recommend to Your Library
Reader Testimonials
Watch the video!
Conversation
Follow us  facebook        Email Alerts
 Tweets
FROM
ISSUE
1547

The FDA has approved Clenpiq (Ferring), a low-volume oral solution that contains sodium picosulfate, magnesium oxide, and anhydrous citric acid, for colon cleansing prior to colonoscopy in adults. The ready-to-drink solution contains the same ingredients as Prepopik, which is supplied as a powder for reconstitution.

COLONOSCOPY PREPARATIONS — Colonoscopy is the preferred method for colorectal cancer screening in the US. Many patients consider cleansing the bowel in preparation for colonoscopy the most unpleasant part of the procedure, but ... Continue reading